Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson u.S. Real Personal Consumption Expenditures — Health Care, SAAR ($B) (DHLCRC1Q027SBEA)
FRED (DHLCRC1Q027SBEA)
Latest, FY2025
3,569.10
Period ended Dec 28, 2025
Change on a year earlier
+7.3%
3,327.20 in FY2024
History
10 years
Since FY2016
Sources
1
FRED (DHLCRC1Q027SBEA)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Real Personal Consumption Expenditures — Health Care, SAAR ($B) (DHLCRC1Q027SBEA) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 28, 2025 | 3,569.10 | +7.3% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2024 | Dec 29, 2024 | 3,327.20 | +8.6% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2023 | Dec 31, 2023 | 3,063.90 | +8.7% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2022 | Jan 1, 2023 | 2,818.20 | +6.7% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2021 | Jan 2, 2022 | 2,642.00 | +12.2% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2020 | Jan 3, 2021 | 2,354.20 | -4.8% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2019 | Dec 29, 2019 | 2,472.40 | +5.4% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2018 | Dec 30, 2018 | 2,344.70 | +4.4% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2017 | Dec 31, 2017 | 2,245.30 | +3.7% | FRED (DHLCRC1Q027SBEA) ↗ |
| FY2016 | Jan 1, 2017 | 2,164.60 | – | FRED (DHLCRC1Q027SBEA) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson U.S. Real Personal Consumption Expenditures — Health Care, SAAR ($B) (DHLCRC1Q027SBEA), annual FY2016–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/fred_pce_healthcare_saar
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.